PRESS RELEASE: Optellum attains CE marking for its early lung cancer diagnosis AI technology

Optellum Virtual Nodule Clinic, including its proprietary artificial intelligence lung cancer prediction solution, has achieved CE certification under the European Union’s Medical Device Regulation. Oxford, UK – 30 March 2022:…

Continue ReadingPRESS RELEASE: Optellum attains CE marking for its early lung cancer diagnosis AI technology

PRESS RELEASE: GE Healthcare and Optellum Join Forces to Advance Lung Cancer Diagnosis with Artificial Intelligence

Oxford, UK/Chalfont St Giles 26 November 2021 13:00 GMT - GE Healthcare and Optellum today announced that they have signed a letter of intent to collaborate to advance precision diagnosis…

Continue ReadingPRESS RELEASE: GE Healthcare and Optellum Join Forces to Advance Lung Cancer Diagnosis with Artificial Intelligence

PRESS RELEASE: Optellum Appoints Jason Pesterfield as CEO to Drive Commercial Growth in the USA

Fast-growing lung-health AI startup strengthens executive team with business leader experienced in medical devices for lung cancer diagnosis. Jason Pesterfield was previously CEO at Veran Medical Technologies, growing it through…

Continue ReadingPRESS RELEASE: Optellum Appoints Jason Pesterfield as CEO to Drive Commercial Growth in the USA